Cargando…
Evolving therapies in the treatment of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors worldwide. The major etiologies and risk factors for HCC development are well defined and some of the steps involved in hepatocarcinogenesis have been elucidated in recent years. Therapeutic options that can be applied in cura...
Autores principales: | Spangenberg, Hans Christian, Thimme, Robert, Blum, Hubert E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2721397/ https://www.ncbi.nlm.nih.gov/pubmed/19707376 |
Ejemplares similares
-
Transarterial Therapy: An Evolving Treatment Modality of Hepatocellular Carcinoma
por: Jazieh, Khalid A., et al.
Publicado: (2014) -
Clinical response to Auron Misheil Therapy in a man with advanced multifocal hepatocellular carcinoma: A case report
por: Scheele, Jürgen S, et al.
Publicado: (2011) -
The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment
por: Leone, Patrizia, et al.
Publicado: (2021) -
Evolving role of Sorafenib in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017) -
Hepatocellular carcinoma: HCC
por: Blum, Hubert E.
Publicado: (2011)